These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36988742)

  • 1. Combined targeted and untargeted high-resolution mass spectrometry analyses to investigate metabolic alterations in pompe disease.
    de Moraes MBM; de Souza HMR; de Oliveira MLC; Peake RWA; Scalco FB; Garrett R
    Metabolomics; 2023 Mar; 19(4):29. PubMed ID: 36988742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a kit for urine collection on filter paper as an alternative for Pompe disease screening and monitoring by LC-HRMS.
    de Souza HMR; Scalco FB; Garrett R; de C Marques FF
    Anal Methods; 2023 Aug; 15(32):3932-3939. PubMed ID: 37539791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tetra-saccharide glucose as a diagnostic biomarker for Pompe disease: a study with 35 patients].
    Bobillo Lobato J; Durán Parejo P; Tejero Díez P; Jiménez Jiménez LM
    Med Clin (Barc); 2013 Aug; 141(3):106-10. PubMed ID: 23756115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.
    Young SP; Zhang H; Corzo D; Thurberg BL; Bali D; Kishnani PS; Millington DS
    Genet Med; 2009 Jul; 11(7):536-41. PubMed ID: 19521244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The decision-making levels of urine tetrasaccharide for the diagnosis of Pompe disease in the Turkish population.
    Canbay E; Vural M; Kalkan Uçar S; Sezer ED; Karasoy H; Yüceyar AN; Çoker M; Sözmen EY
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):391-395. PubMed ID: 32069240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases.
    Manwaring V; Prunty H; Bainbridge K; Burke D; Finnegan N; Franses R; Lam A; Vellodi A; Heales S
    J Inherit Metab Dis; 2012 Mar; 35(2):311-6. PubMed ID: 21687968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting lysosomal storage disorders by glycomic profiling using liquid chromatography mass spectrometry.
    Mak J; Cowan TM
    Mol Genet Metab; 2021; 134(1-2):43-52. PubMed ID: 34474962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease.
    An Y; Young SP; Kishnani PS; Millington DS; Amalfitano A; Corz D; Chen YT
    Mol Genet Metab; 2005 Aug; 85(4):247-54. PubMed ID: 15886040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of urinary oligosaccharide excretion patterns by UHPLC/HRAM mass spectrometry for screening of lysosomal storage disorders.
    Hagemeijer MC; van den Bosch JC; Bongaerts M; Jacobs EH; van den Hout JMP; Oussoren E; Ruijter GJG
    J Inherit Metab Dis; 2023 Mar; 46(2):206-219. PubMed ID: 36752951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of patients with Pompé disease using routine pathology results: PATHFINDER (creatine kinase) study.
    Reynolds TM; Tylee K; Booth K; Wierzbicki AS; ;
    J Clin Pathol; 2019 Dec; 72(12):805-809. PubMed ID: 31308256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases.
    Sluiter W; van den Bosch JC; Goudriaan DA; van Gelder CM; de Vries JM; Huijmans JG; Reuser AJ; van der Ploeg AT; Ruijter GJ
    Clin Chem; 2012 Jul; 58(7):1139-47. PubMed ID: 22623745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing lysosomal storage disorders: Pompe disease.
    Bodamer OA; Dajnoki A
    Curr Protoc Hum Genet; 2012 Oct; Chapter 17():Unit17.11. PubMed ID: 23074069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry.
    Dajnoki A; Mühl A; Fekete G; Keutzer J; Orsini J; Dejesus V; Zhang XK; Bodamer OA
    Clin Chem; 2008 Oct; 54(10):1624-9. PubMed ID: 18703766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening.
    Chien YH; Goldstein JL; Hwu WL; Smith PB; Lee NC; Chiang SC; Tolun AA; Zhang H; Vaisnins AE; Millington DS; Kishnani PS; Young SP
    JIMD Rep; 2015; 19():67-73. PubMed ID: 25681082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new UHPLC-MS/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders.
    Semeraro M; Sacchetti E; Deodato F; Coşkun T; Lay I; Catesini G; Olivieri G; Rizzo C; Boenzi S; Dionisi-Vici C
    Orphanet J Rare Dis; 2021 Jan; 16(1):24. PubMed ID: 33422100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
    Young SP; Piraud M; Goldstein JL; Zhang H; Rehder C; Laforet P; Kishnani PS; Millington DS; Bashir MR; Bali DS
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):50-8. PubMed ID: 22252961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted LC-HRMS metabolomics reveals candidate biomarkers for mucopolysaccharidoses.
    Torres CL; Scalco FB; de Oliveira MLC; Peake RWA; Garrett R
    Clin Chim Acta; 2023 Feb; 541():117250. PubMed ID: 36764508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for Pompe disease in Italy: Long-term results and future challenges.
    Gragnaniello V; Pijnappel PWWM; Burlina AP; In 't Groen SLM; Gueraldi D; Cazzorla C; Maines E; Polo G; Salviati L; Di Salvo G; Burlina AB
    Mol Genet Metab Rep; 2022 Dec; 33():100929. PubMed ID: 36310651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry.
    Rozaklis T; Ramsay SL; Whitfield PD; Ranieri E; Hopwood JJ; Meikle PJ
    Clin Chem; 2002 Jan; 48(1):131-9. PubMed ID: 11751548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease.
    An Y; Young SP; Hillman SL; Van Hove JL; Chen YT; Millington DS
    Anal Biochem; 2000 Dec; 287(1):136-43. PubMed ID: 11078593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.